Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 63, Issue 10, 2011, Pages 3067-3077

  Nielsen, Christoffer T ^a   Østergaard, Ole ^a   Johnsen, Christina ^a   Jacobsen, Søren ^b   Heegaard, Niels H H ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; CITRIC ACID; ENDOTHELIAL CELL ANTIBODY; LEUKOCYTE ANTIBODY; LIPOCORTIN 5; THROMBOCYTE ANTIBODY; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CELL ISOLATION; CELL SUBPOPULATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; NEPHRITIS; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE;

ADULT; AGED; ANNEXIN A5; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 80053540693     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30499     Document Type: Article

References (49)

1. Rahman A, Isenberg DA,. Systemic lupus erythematosus [review]. N Engl J Med 2008; 358: 929-39. (Pubitemid 351397092)
2. Ronnblom L, Pascual V,. The innate immune system in SLE: type I interferons and dendritic cells [review]. Lupus 2008; 17: 394-9. (Pubitemid 351798715)
3. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M,. The role of defective clearance of apoptotic cells in systemic autoimmunity [review]. Nat Rev Rheumatol 2010; 6: 280-9.
4. Cline AM, Radic MZ,. Apoptosis, subcellular particles, and autoimmunity [review]. Clin Immunol 2004; 112: 175-82. (Pubitemid 38881483)
5. Piccin A, Murphy WG, Smith OP,. Circulating microparticles: pathophysiology and clinical implications [review]. Blood Rev 2007; 21: 157-71. (Pubitemid 46529055)
6. Cocucci E, Racchetti G, Meldolesi J,. Shedding microvesicles: artefacts no more [review]. Trends Cell Biol 2009; 19: 43-51.
7. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS,. Microparticles as mediators of cellular cross-talk in inflammatory disease [review]. Autoimmunity 2006; 39: 683-90. (Pubitemid 44964371)
8. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO,. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-9. (Pubitemid 47214727)
9. Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biro E, Nieuwland R, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1842-51. (Pubitemid 40197488)
10. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009; 15: 6830-40.
11. Casciola-Rosen LA, Anhalt G, Rosen A,. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-30. (Pubitemid 24091790)
12. Abid Hussein MN, Meesters EW, Osmanovic N, Romijn FP, Nieuwland R, Sturk A,. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost 2003; 1: 2434-43.
13. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102. (Pubitemid 29534349)
14. Dignat-George F, Camoin-Jau L, Sabatier F, Arnoux D, Anfosso F, Bardin N, et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost 2004; 91: 667-73. (Pubitemid 38477445)
15. Flores-Nascimento MC, Beltrame MP, De Paula EV, Montalvao SL, Pereira FG, Orsi FL, et al. Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden. Platelets 2009; 20: 367-75.
16. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ,. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001; 115: 451-9. (Pubitemid 34203516)
17. Jy W, Tiede M, Bidot CJ, Horstman LL, Jimenez JJ, Chirinos J, et al. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Thromb Res 2007; 121: 319-25.
18. Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L, et al. Circulating platelet-derived microparticles in systemic lupus erythematosus: association with increased thrombin generation and procoagulant state. Thromb Haemost 2006; 95: 94-9.
19. Sellam J, Proulle V, Jungel A, Ittah M, Miceli RC, Gottenberg JE, et al. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009; 11: R156.
20. Cline AM, Radic MZ,. Murine lupus autoantibodies identify distinct subsets of apoptotic bodies. Autoimmunity 2004; 37: 85-93. (Pubitemid 38594272)
21. Connor DE, Exner T, Ma DD, Joseph JE,. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010; 103: 1044-52.
22. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS,. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003; 109: 175-80. (Pubitemid 36712905)
23. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001; 85: 810-20. (Pubitemid 32421813)
24. Key NS,. Analysis of tissue factor positive microparticles. Thromb Res 2010; 125 Suppl 1: S42-5.
25. Ravichandran KS, Lorenz U,. Engulfment of apoptotic cells: signals for a good meal [review]. Nat Rev Immunol 2007; 7: 964-74. (Pubitemid 350166061)
26. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
27. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosusIDisease manifestations and analyses of clinical subsets. Clin Rheumatol 1998; 17: 468-77. (Pubitemid 28566323)
28. Petri M, Buyon J, Kim M,. Classification and definition of major flares in SLE clinical trials [review]. Lupus 1999; 8: 685-91. (Pubitemid 29520536)
29. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-9. (Pubitemid 26085211)
30. Dachary-Prigent J, Freyssinet JM, Pasquet JM, Carron JC, Nurden AT,. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-65. (Pubitemid 23147557)
31. Gyorgy B, Modos K, Pallinger E, Paloczi K, Pasztoi M, Misjak P, et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes due to shared biophysical parameters. Blood 2011; 117: e39-48.
32. Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011; 127: 370-7.
33. Maurer-Spurej E, Pfeiler G, Maurer N, Lindner H, Glatter O, Devine DV,. Room temperature activates human blood platelets. Lab Invest 2001; 81: 581-92. (Pubitemid 32298804)
34. Erdbruegger U, Grossheim M, Hertel B, Wyss K, Kirsch T, Woywodt A, et al. Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford) 2008; 47: 1820-5.
35. Berckmans RJ, Nieuwland R, Tak PP, Boing AN, Romijn FP, Kraan MC, et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 2002; 46: 2857-66. (Pubitemid 35315876)
36. Biro E, Nieuwland R, Tak PP, Pronk LM, Schaap MC, Sturk A, et al. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis 2007; 66: 1085-92. (Pubitemid 47122324)
37. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA,. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002; 46: 1498-503. (Pubitemid 34620195)
38. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, et al. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Autoimmunity 2009; 42: 497-506.
39. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2407-15. (Pubitemid 37542989)
40. Borba EF, Bonfa E,. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 1997; 6: 533-9. (Pubitemid 27371222)
41. Borba EF, Bonfa E, Vinagre CG, Ramires JA, Maranhao RC,. Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 1033-40. (Pubitemid 30368180)
42. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-406. (Pubitemid 37542988)
43. Mevorach D, Zhou JL, Song X, Elkon KB,. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998; 188: 387-92. (Pubitemid 28357766)
44. Abid Hussein MN, Nieuwland R, Hau CM, Evers LM, Meesters EW, Sturk A,. Cell-derived microparticles contain caspase 3 in vitro and in vivo. J Thromb Haemost 2005; 3: 888-96. (Pubitemid 41632816)
45. Guiducci S, Distler JH, Jungel A, Huscher D, Huber LC, Michel BA, et al. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum 2008; 58: 2845-53.
46. Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001; 56: 1319-24. (Pubitemid 32455291)
47. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002; 51: 2840-5. (Pubitemid 34970939)
48. Soriano AO, Jy W, Chirinos JA, Valdivia MA, Velasquez HS, Jimenez JJ, et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med 2005; 33: 2540-6. (Pubitemid 41682106)
49. Ay C, Freyssinet JM, Sailer T, Vormittag R, Pabinger I,. Circulating procoagulant microparticles in patients with venous thromboembolism. Thromb Res 2009; 123: 724-6.